1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Cothera Bioscience, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma Sepantronium Bromide - High-grade B-cell Lymphoma, Burkitt Lymphoma | Phase 2 | Completed | Cothera Bioscience, Inc | 14 | 2022-12-03 | 2026-11-04 |
Burkitt Lymphoma (1) · Lymphatic Diseases (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Recurrence (1)
sepantronium (1)
China (1) · South Korea (1)